摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

结香素 | 120028-43-5

中文名称
结香素
中文别名
2H-1-苯并吡喃-2-酮,7-羟基-3-[(2-羰基-2H-1-苯并吡喃-7-基)氧代]-
英文名称
edgeworin
英文别名
7-hydroxy-3-(2-oxochromen-7-yl)oxychromen-2-one
结香素化学式
CAS
120028-43-5
化学式
C18H10O6
mdl
——
分子量
322.274
InChiKey
WNLKKLCKMRDNHF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    284-296℃
  • 沸点:
    617.0±55.0 °C(Predicted)
  • 密度:
    1.529±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    24
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    82.1
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    结香素乙酸酐吡啶 为溶剂, 以0.11 g的产率得到Acetic acid 2-oxo-3-(2-oxo-2H-chromen-7-yloxy)-2H-chromen-7-yl ester
    参考文献:
    名称:
    来自Edgeworthia chrysantha的香豆素☆
    摘要:
    摘要 从 Edgeworthia chrysantha ( E. papyrifera ) 的根和茎中分离到了两种新的香豆素,edgeworin 和 edgeworoside A,其结构确定为 3-(7-coumarinyloxy)-7-hydroxycoumarin 和 3-(7-coumarinyloxy)- 8-(7-羟基香豆素-8-基)-7-α-1-鼠李糖基氧基香豆素。
    DOI:
    10.1016/0031-9422(89)85042-3
  • 作为产物:
    描述:
    3-(7-coumarinyloxy)-4-bromo-7-methoxycoumarin 在 盐酸三氯化铝 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 49.5h, 生成 结香素
    参考文献:
    名称:
    New Total Synthesis of O‐Methyledgeworin and Edgeworin
    摘要:
    Upon thermal condensation of diethyl (coumarinyl-7-oxy)malonate with O-methyl-resorcine, the corresponding bis[coumarinyl]ether, 4-hydroxy-O-methyledgeworin is obtained in good yield. This leads to 4-bromo-O-methyledgeworin, O-methyledgeworin, and edgeworin.
    DOI:
    10.1080/00397910500406088
点击查看最新优质反应信息

文献信息

  • Inhibitors of DNA polymerase β: Activity and mechanism
    作者:Zhijie Gao、David J. Maloney、Larisa M. Dedkova、Sidney M. Hecht
    DOI:10.1016/j.bmc.2008.02.071
    日期:2008.4
    Bioassay-guided fractionation of extracts prepared from Couepia polyandra and Edgeworthia gardneri resulted in the isolation of the DNA polymerase beta (pol beta) inhibitors oleanolic acid (1), edgeworin (2), betulinic acid (3), and stigmasterol (4). Study of these pol b inhibitors revealed that three of them inhibited both the lyase and polymerase activities of DNA polymerase beta, while stigmasterol inhibited only the lyase activity. Further investigation indicated that the four inhibitors had substantially different effects on the DNA-pol beta binary complex that is believed to be an obligatory intermediate in the lyase reaction. It was found that the inhibitors potentiated the inhibitory action of the anticancer drug bleomycin in cultured A549 cells, without any influence on the expression of pol beta in the cells. The results of the unscheduled DNA synthesis assay support the thesis that the potentiation of bleomycin cytotoxicity by DNA pol beta inhibitors was a result of an inhibition of DNA repair synthesis. (C) 2008 Elsevier Ltd. All rights reserved.
  • BABA, KIMIYE;TABATA, YUKO;TANIGUTI, MASAHIKO;KOZAWA, MITSUGI, PHYTOCHEMISTRY, 28,(1989) N 1, C. 221-225
    作者:BABA, KIMIYE、TABATA, YUKO、TANIGUTI, MASAHIKO、KOZAWA, MITSUGI
    DOI:——
    日期:——
  • METHODS FOR DIRECTING DIFFERENTIATION OF CLONOGENIC NEURAL STEM CELLS WITH COUMARINS
    申请人:HE Cheng
    公开号:US20090170930A1
    公开(公告)日:2009-07-02
    A method for promoting differentiation of clonogenic neural stem cells (NSCs), comprising administering to a patient in the need of such promoting a coumarin compound represented by formula I or by formula II. The representative coumarin compounds include 7-hydroxycoumarin, daphnoretin, scopoletin, edgeworin, aesculetin and esculetin-6-β-D-glucopyranoside. The coumarin compounds showed significant activity of directing the differentiation of NSCs in pharmacological test and thereof could be used to prepare drugs to direct NSCs differentiated to oligodendrocyte progenitor cells (OPCs) for the treatment of demyelinating diseases or spinal cord injury. The drug could be a pure coumarin compound or a pharmaceutical composition comprising a therapeutical dose of a coumarin compound as active ingredients and a pharmaceutically-acceptable carrier. The content of the active ingredients in the pharmaceutical composition is between 0.1% and 99.5% by weight.
  • Coumarins from Edgeworthia chrysantha☆
    作者:Kimiye Baba、Yuko Tabata、Masahiko Taniguti、Mitsugi Kozawa
    DOI:10.1016/0031-9422(89)85042-3
    日期:——
    Abstract Two new coumarins, edgeworin and edgeworoside A, were isolated from the root and stem of Edgeworthia chrysantha ( E. papyrifera ) and their structures determined as 3-(7-coumarinyloxy)-7-hydroxycoumarin and 3-(7-coumarinyloxy)-8-(7-hydroxycoumarin-8-yl)-7-α- l -rhamnopyranosyloxycoumarin.
    摘要 从 Edgeworthia chrysantha ( E. papyrifera ) 的根和茎中分离到了两种新的香豆素,edgeworin 和 edgeworoside A,其结构确定为 3-(7-coumarinyloxy)-7-hydroxycoumarin 和 3-(7-coumarinyloxy)- 8-(7-羟基香豆素-8-基)-7-α-1-鼠李糖基氧基香豆素。
  • New Total Synthesis of O‐Methyledgeworin and Edgeworin
    作者:B. Serge Kirkiacharian、Marie Brillard
    DOI:10.1080/00397910500406088
    日期:2006.3.1
    Upon thermal condensation of diethyl (coumarinyl-7-oxy)malonate with O-methyl-resorcine, the corresponding bis[coumarinyl]ether, 4-hydroxy-O-methyledgeworin is obtained in good yield. This leads to 4-bromo-O-methyledgeworin, O-methyledgeworin, and edgeworin.
查看更多